INOVIO PHARMACEUTICALS, INC. - Common Stock (INO)

Historical Holders from Q4 2023 to Q3 2025

Symbol
INO on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
66.7M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
20.7M
Holdings value
$48.4M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
98
Number of buys
46
Number of sells
-54
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 14.8% $19.2M 9.85M FMR LLC 28 Nov 2025
JANUS HENDERSON GROUP PLC 9.99% +63.2% $13M $6.63M 6.67M +104% JANUS HENDERSON GROUP PLC 28 Nov 2025
Adage Capital Management, L.P. 9.99% $12.9M 5.52M Adage Capital Management, L.P. 30 Sep 2025
Alyeska Investment Group, L.P. 7.53% $9.36M 4M Alyeska Investment Group, L.P. 30 Sep 2025
HIGHBRIDGE CAPITAL MANAGEMENT LLC 9.2% $6.79M 3.63M Highbridge Capital Management, LLC 31 Dec 2024
VANGUARD GROUP INC 5.53% +17.8% $3.79M $665K 2.03M +21.2% The Vanguard Group 31 Mar 2025
Stonepine Capital Management, LLC 3.8% -28% $2.68M -$901K 1.43M -25.1% Stonepine Capital Management, LLC 31 Mar 2025
Deep Track Capital, LP 2.41% $3.08M 1.31M Deep Track Capital, LP 30 Sep 2025
BlackRock, Inc. 1.5% -80% $1.1M -$3.64M 538K -76.8% BlackRock, Inc. 30 Jun 2025

Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 20.7M $48.4M +$25.4M $2.34 98
2025 Q2 10.2M $20.7M -$6.58M $2.04 101
2025 Q1 13.6M $22.2M +$52K $1.63 105
2024 Q4 13.3M $24.4M +$7.46M $1.83 100
2024 Q3 8.57M $49.5M +$2.1M $5.78 95
2024 Q2 8.06M $65.1M +$29.6M $8.08 92
2024 Q1 4.04M $56.1M +$53.7M $13.88 83
2023 Q4 299K $153K +$153K $0.51 7